Synchrony Financial (SYF) Business Profile

What it does

Synchrony Financial is a consumer-finance company founded in 2003 and headquartered in Stamford. Brian Doubles is its President and Chief Executive Officer. It provides credit products through programs established with national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers.

For consumers, the company offers private-label cards that work with a particular merchant, Dual Cards, co-branded cards, general-purpose credit cards, and short- and long-term installment loans. These products let consumers finance purchases, receive partner-linked rewards or promotional offers, and in some cases use the card beyond a partner’s own sales channels. Its CareCredit offering is used for health and wellness purchases, while its other platforms include diversified value, home and auto, lifestyle, and digital.

The company also operates Synchrony Bank, which offers FDIC-insured savings products. The bank gathers deposits that help fund consumer loans. Synchrony services the accounts and manages credit risk, including underwriting applicants, setting credit terms, collecting repayments and managing delinquent balances. It operates through one business segment.

Management said on the Q3 2026 call that the company serves more than 68 million customers and hundreds of thousands of merchants, partners and providers. Management also said that CareCredit PayLater is an installment-loan option offered alongside the CareCredit credit card for eligible health and wellness customers.

How it makes money

Synchrony earns interest and fees on consumer loan receivables. Its card and installment-loan programs generate balances when cardholders and borrowers finance purchases; interest income and fees recur while those balances remain outstanding. The company also earns interchange revenue when cards are used for purchases, as well as protection-product revenue.

A central economic feature is its retailer share arrangements. Synchrony pays participating retailers or partners a share tied to program economics, so this expense rises or falls with portfolio and program performance. Loyalty programs are another recurring cost of supporting card rewards and offers. Credit losses are a core cost because the company records provisions for expected losses on its loan receivables.

Funding comes primarily from deposits gathered by Synchrony Bank, supplemented by securitization borrowings and senior and subordinated unsecured notes. Interest paid on deposits and borrowings is therefore an expense that affects the margin earned between the yield on loans and funding costs. The company also holds cash and debt securities.

For the year ended December 31, 2025, Synchrony reported net earnings; in Q3 2026, management reported net earnings of $892 million, or $2.68 per diluted share. Management said Q3 2026 net interest income increased 2% to $4.8 billion, while ending loan receivables increased 3% to $103 billion. Management expects approximately $9.50 in diluted earnings per share for full-year 2026.

Customers and how it sells

Synchrony’s customers include individual cardholders and borrowers, plus the retailers, merchants, healthcare providers and other partners that offer its financing at the point of sale. Its programs cover purchases ranging from retail and apparel to home and auto, health and wellness, and digital commerce.

The company primarily operates in the United States, and substantially all of its revenue comes from U.S. customers. Management said on the Q3 2026 call that it serves more than 68 million customers. Its partner network includes hundreds of thousands of merchants, partners and providers.

CareCredit is a channel for health and wellness financing. Management said that more than 12 million CareCredit cardholders, as well as new approved applicants, can access CareCredit financing through participating Stripe providers. CareCredit PayLater was available at nearly 20,000 health and wellness locations, including dental, cosmetic, vision and audiology providers. Management also said that Vetspire is used by more than 1,000 veterinary hospitals and clinics nationwide, with about 85% already CareCredit-enrolled providers.

Distribution increasingly includes partner locations, online checkout, digital wallets, partner apps and AI-enabled purchasing paths. Management said that its Stripe integration enables providers and health and wellness retailers to offer CareCredit financing in online checkout.

Suppliers and costs

Synchrony does not manufacture physical goods. Its principal operating inputs are funding, employees, technology, data and analytics, marketing, professional services, servicing operations, and arrangements with retailers and other program partners.

Deposits are its largest funding source, alongside securitized debt and unsecured notes. The cost of those sources appears as interest expense. Employee costs, professional fees, marketing and business development, information processing, and other operating costs make up its non-interest expense base.

Credit costs are material because the company lends to consumers. Provisions for credit losses and retailer share arrangements are material costs. Management said Q3 2026 other expense increased 10% to $1.4 billion, driven by higher operational losses, technology investments and marketing expenditures. Management also reported that deposits represented 83% of total funding at the end of Q3 2026.

Competitive position

No specific company is identified as a competitor in the available information. Management said on the Q3 2026 call that the competitors it sees in requests for proposals and its traditional business have been broadly consistent for the past three or four years, while terms and pricing for merchant and provider business remained rational. Management described Stripe as a payment processor rather than a retailer, and as a one-to-many distribution channel for its products.

Synchrony competes to win and retain financing programs with merchants, providers and partners. Its relevant differentiators include its partner relationships, the range of cards and installment products it can offer, underwriting, servicing, rewards and promotional value propositions, and the availability of financing across physical and digital checkout channels.

Our reading: The partner-program model is a medium-strength moat because renewals, new-program wins and integrations can embed Synchrony’s products in merchant and provider workflows, but the company must keep winning or renewing those programs. (call_prepared)

Our reading: PRISM is a medium-strength underwriting moat because it uses more than 9,000 data variables and cash-flow underwriting; its advantage depends on continued credit performance and execution. (call_prepared)

Our reading: CareCredit’s cardholder and provider network is a medium-strength distribution moat, supported by its Stripe and Vetspire integrations, but those channels are still being expanded. (call_prepared)

Growth opportunities

Synchrony’s growth initiatives center on adding and renewing partner programs, growing purchase volume and loan receivables, broadening CareCredit distribution, and making its financing products available in digital commerce. Management said it added or renewed more than 15 partners in Q2 2026, including Suzuki Motor, AmeriVet and Roto-Rooter, and that it generated more than 5.1 million new accounts during that quarter.

Management said on the Q3 2026 call that total purchase volume reached nearly $50 billion, up 8% from the prior year. Co-branded cards accounted for approximately 53% of third-quarter spend, and co-branded-card spending increased 23% year over year. Ending loan receivables increased 3% to $103 billion.

The company is extending CareCredit through Stripe’s online checkout network and Vetspire’s veterinary-practice-management platform. It has also launched a ChatGPT plugin that lets consumers discover Synchrony marketplace savings, offers and promotional-financing deals, and it is deploying OpenAI models for product development and technology innovation.

Management expects year-end loan receivables to grow by mid-single digits in 2026. It expects net interest income to increase, net charge-offs to be less than 5.5%, and other-expense dollars in the fourth quarter to be generally in line with Q3 as it invests in capabilities and future growth opportunities.

Bottom line

Our reading

Our reading: Synchrony is a U.S. consumer lender whose economics combine interest income and card-related revenue with substantial funding, partner-sharing and credit-loss costs. Its business rests on partner-distributed financing programs and deposit funding, while CareCredit and digital integrations extend where its products can be offered. (item1; call_prepared)

Our reading: The main operating sensitivities are consumer repayment behavior, credit losses, deposit costs and the ability to retain or win partner programs; elevated payment rates can also constrain loan-balance growth despite purchase-volume growth. (call_prepared)

Our reading: The Q3 2026 results show expanding purchase volume and receivables alongside continued technology and marketing investment, with AI and digital-checkout initiatives positioned as distribution channels rather than separate reported segments. (call_prepared)